These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24829097)

  • 1. Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis.
    Nakamura S; Takano H; Kubota Y; Asai K; Shimizu W
    J Thromb Haemost; 2014 Jul; 12(7):1086-95. PubMed ID: 24829097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolytic therapy for pulmonary embolism.
    Zuo Z; Yue J; Dong BR; Wu T; Liu GJ; Hao Q
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD004437. PubMed ID: 33857326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Efficacy and Safety of Thrombolytic Agents for Pulmonary Embolism: A Bayesian Network Meta-Analysis.
    Li HY; Wang YB; Ren XY; Wang J; Wang HS; Jin YH
    Pharmacology; 2023; 108(2):111-126. PubMed ID: 36603558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolytic therapy for pulmonary embolism.
    Hao Q; Dong BR; Yue J; Wu T; Liu GJ
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD004437. PubMed ID: 30560579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Efficacy and Safety between Thrombolysis Plus Anticoagulation vs. Anticoagulation Alone for the Treatment of Acute Submassive Pulmonary Embolism: A Systematic Review and Meta-analysis.
    Pan Q; Gao H; Wang Y; Chen Q
    Curr Vasc Pharmacol; 2022; 20(6):491-500. PubMed ID: 35959626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based emergency medicine/critically appraised topic. Thrombolytic therapy for submassive pulmonary embolism?
    Worster A; Smith C; Silver S; Brown MD
    Ann Emerg Med; 2007 Jul; 50(1):78-84. PubMed ID: 17449142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic therapy for pulmonary embolism.
    Hao Q; Dong BR; Yue J; Wu T; Liu GJ
    Cochrane Database Syst Rev; 2015 Sep; (9):CD004437. PubMed ID: 26419832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of clot-dissolving therapies for submassive pulmonary embolism: A network meta-analysis of randomized controlled trials.
    Al Hennawi H; Khedr A; Khan MK; Ashraf MT; Sohail A; Mathbout L; Eissa A; Mathbout M; Klugherz B
    Cardiovasc Revasc Med; 2024 May; 62():73-81. PubMed ID: 38176962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials.
    Wan S; Quinlan DJ; Agnelli G; Eikelboom JW
    Circulation; 2004 Aug; 110(6):744-9. PubMed ID: 15262836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis.
    Marti C; John G; Konstantinides S; Combescure C; Sanchez O; Lankeit M; Meyer G; Perrier A
    Eur Heart J; 2015 Mar; 36(10):605-14. PubMed ID: 24917641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis versus anticoagulation for the initial treatment of moderate pulmonary embolism: a meta-analysis of randomized controlled trials.
    Chen H; Ren C; Chen H
    Respir Care; 2014 Dec; 59(12):1880-7. PubMed ID: 25269681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Thrombolytic Therapy for Massive and Submassive Pulmonary Embolism.
    Igneri LA; Hammer JM
    J Pharm Pract; 2020 Feb; 33(1):74-89. PubMed ID: 29673293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Controversies in Thrombolytic Use in Acute Pulmonary Embolism.
    Long B; Koyfman A
    J Emerg Med; 2016 Jul; 51(1):37-44. PubMed ID: 27071316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolytic therapy of pulmonary embolism: a meta-analysis.
    Thabut G; Thabut D; Myers RP; Bernard-Chabert B; Marrash-Chahla R; Mal H; Fournier M
    J Am Coll Cardiol; 2002 Nov; 40(9):1660-7. PubMed ID: 12427420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter-directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism.
    Harvey JJ; Huang S; Uberoi R
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD013083. PubMed ID: 35938605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis.
    Agnelli G; Becattini C; Kirschstein T
    Arch Intern Med; 2002 Dec 9-23; 162(22):2537-41. PubMed ID: 12456225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose systemic thrombolytic therapy for treatment of submassive pulmonary embolism: Clinical efficacy but attendant hemorrhagic risks.
    Rothschild DP; Goldstein JA; Bowers TR
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):506-510. PubMed ID: 30549393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolysis for acute intermediate-risk pulmonary embolism: A meta-analysis.
    Gao GY; Yang P; Liu M; Ding M; Liu GH; Tong YL; Yang CY; Meng FB
    Thromb Res; 2015 Nov; 136(5):932-7. PubMed ID: 26384442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible gender-related differences in the risk-to-benefit ratio of thrombolysis for acute submassive pulmonary embolism.
    Geibel A; Olschewski M; Zehender M; Wilsch M; Odening K; Heinrich F; Kasper W; Konstantinides S
    Am J Cardiol; 2007 Jan; 99(1):103-7. PubMed ID: 17196471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should thrombolytic therapy be used in patients with pulmonary embolism?
    Konstantinides S
    Am J Cardiovasc Drugs; 2004; 4(2):69-74. PubMed ID: 15049719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.